Wedbush Securities’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$354K Sell
8,452
-500
-6% -$22.5K 0.01% 875
2026
Q2
$413K Sell
8,952
-1,512
-14% -$61K 0.01% 791
2026
Q1
$347K Sell
10,464
-378
-3% -$12.3K 0.01% 827
2025
Q4
$355K Buy
+10,842
New +$267K 0.01% 811

Other funds holding AXGN

Wedbush Securities's AXGN Position: Q3 2026 in Review

Wedbush Securities reduced its Axogen (AXGN) stake by 5.6% in Q3 2026, selling an estimated $22.5K and leaving 8,452 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #875.

Wedbush Securities first reported a position in AXGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $413K in Q2 2026. 253 funds tracked by Wall St. Rank hold AXGN as of Q3 2026.

  • Wedbush Securities held 8,452 shares of Axogen worth $354K as of Q3 2026.
  • Wedbush Securities sold 500 Axogen shares in Q3 2026, an estimated $22.5K.
  • Axogen made up 0.01% of Wedbush Securities's portfolio in Q3 2026, its #875 holding.
  • Wedbush Securities first reported a position in Axogen in Q4 2025 and has held it in 4 quarters since.
  • Wedbush Securities's Axogen position peaked at $413K in Q2 2026.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q3 2026.

Based on Wedbush Securities's 13F filing for Q3 2026, filed 22 Oct 2026.